How to buy Genpact stock | $45.74

Genpact Limited is an information technology services business based in the US. Genpact shares (G) are listed on the NYSE and all prices are listed in US Dollars. Genpact employs 98,000 staff and has a trailing 12-month revenue of around 0.00.

Genpact stock price (NYSE: G)

Use our graph to track the performance of G stocks over time.

Genpact shares at a glance

• Key figures

Information last updated 2021-07-24.

Latest market close	$45.74
52-week range	$33.66 - $49.63
50-day moving average	$46.29
200-day moving average	$43.87
Wall St. target price	$51.67
PE ratio	31.0256
Dividend yield	$0.4 (0.82%)
Earnings per share (TTM)	$1.60

Buy Genpact shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Genpact stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Genpact Limited by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Genpact price performance over time

Historical closes compared with the close of $45.74 from 2021-05-28

1 week (2021-07-18)	N/A
1 month (2021-06-29)	0.68%
3 months (2021-04-29)	-5.48%
6 months (2021-01-25)	N/A

1 year (2020-07-25)	N/A
2 years (2019-07-25)	N/A
3 years (2018-07-25)	N/A
5 years (2016-07-25)	N/A

Is Genpact under- or over-valued?

Valuing Genpact stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genpact's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Genpact's P/E ratio

Genpact's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, Genpact shares trade at around 31x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Genpact's PEG ratio

Genpact's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Genpact's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Genpact's EBITDA

Genpact's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $653.8 million.

The EBITDA is a measure of a Genpact's overall financial performance and is widely used to measure a its profitability.

Genpact financials

Revenue TTM	$3.7 billion
Operating margin TTM	13.29%
Gross profit TTM	$1.3 billion
Return on assets TTM	6.75%
Return on equity TTM	18.89%
Profit margin	8.41%
Book value	$9.35
Market capitalisation	$9.3 billion

TTM: trailing 12 months

Shorting Genpact shares

There are currently 3.9 million Genpact shares held short by investors – that's known as Genpact's "short interest". This figure is 18.8% down from 4.8 million last month.

There are a few different ways that this level of interest in shorting Genpact shares can be evaluated.

Genpact's "short interest ratio" (SIR)

Genpact's "short interest ratio" (SIR) is the quantity of Genpact shares currently shorted divided by the average quantity of Genpact shares traded daily (recently around 1.0 million). Genpact's SIR currently stands at 3.83. In other words for every 100,000 Genpact shares traded daily on the market, roughly 3830 shares are currently held short.

However Genpact's short interest can also be evaluated against the total number of Genpact shares, or, against the total number of tradable Genpact shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Genpact's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Genpact shares in existence, roughly 20 shares are currently held short) or 0.0225% of the tradable shares (for every 100,000 tradable Genpact shares, roughly 23 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Genpact.

Find out more about how you can short Genpact stock.

Genpact share dividends

Dividend payout ratio: 18.81% of net profits

Recently Genpact has paid out, on average, around 18.81% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.87% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Genpact shareholders could enjoy a 0.87% return on their shares, in the form of dividend payments. In Genpact's case, that would currently equate to about $0.4 per share.

While Genpact's payout ratio might seem low, this can signify that Genpact is investing more in its future growth.

Genpact's most recent dividend payout was on 22 June 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 June 2021 (the "ex-dividend date").

Genpact share price volatility

Over the last 12 months, Genpact's shares have ranged in value from as little as $33.6603 up to $49.63. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Genpact's is 1.4151. This would suggest that Genpact's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Genpact overview

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. It operates in three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company's finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. It also provides supply chain design, planning, inventory optimization, transportation and logistics management, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, master data management, and other procurement and supply chain advisory services; and sales and commercial services in the lead-to-quote, quote-to-order, and customer service areas. In addition, the company offers IT services, which include end-user computing support, infrastructure management, application production support, and database management services; and transformation services that include digital solutions, consulting services, and analytics services and solutions. It serves banking, capital market, insurance, consumer goods, retail, life science, healthcare, high tech, and manufacturing and service industries. Genpact Limited was founded in 1997 and is based in Hamilton, Bermuda.

Frequently asked questions

What percentage of Genpact is owned by insiders or institutions?
Currently 0.483% of Genpact shares are held by insiders and 104.117% by institutions. How many people work for Genpact?
Latest data suggests 98,000 work at Genpact. When does the fiscal year end for Genpact?
Genpact's fiscal year ends in December. Where is Genpact based?
Genpact's address is: Victoria Place, Hamilton, Bermuda, HM 10 What is Genpact's ISIN number?
Genpact's international securities identification number is: BMG3922B1072 What is Genpact's CUSIP number?
Genpact's Committee on Uniform Securities Identification Procedures number is: G3922B107